Download Citation
Article Source:
Tocilizumab, netakimab, and baricitinib in patients with mild-to-moderate COVID-19: An observational study
Bryushkova EA,
Skatova VD,
Mutovina ZY,
Zagrebneva AI,
Fomina DS,
et al.
(2022)
Tocilizumab, netakimab, and baricitinib in patients with mild-to-moderate COVID-19: An observational study.
PLOS ONE 17(8): e0273340.
https://doi.org/10.1371/journal.pone.0273340